Toronto Star - Business VANCOUVER - Ritchie Bros. Auctioneers Inc. announced it has closed its acquisition of U.S. firm IAA Inc. after a contentious few months that saw shareholders divided over the deal. Shareholders of the Vancouver-based auction company voted to approve the deal last Tuesday, as did shareholders in IAA, an automotive salvage company.\n more…
Ticker Report Peregrine Capital Management LLC cut its stake in shares of IAA, Inc. (NYSE:IAA Get Rating) by 3.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 158,042 shares of the companys stock after ...\n more…
Zolmax Shares of IAA, Inc. (NYSE:IAA Get Rating) have received an average rating of Hold from the seven brokerages that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy ...\n more…
Transport Topics Shareholders of heavy equipment auctioneer Ritchie Bros. approved the companys plan to acquire vehicle-seller IAA Inc., ending a battle to block the $6 billion deal...\n more…
Business Wire IAA, Inc. (NYSE: IAA) (the Company) today announced that its stockholders have adopted the previously announced merger agreement providing for the stock and cash acquisition of the Company by Ritchie Bros. Auctioneers Incorporated (NYSE: RBA) (TSX: RBA) (Ritchie Bros.) at the Special Meeting of IAA...\n more…
WNYT NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday: Altria Group Inc., up 66 cents to $47.19. The maker of Marlboro cigarettes announced a $2.75 billion investment in electronic cigarette startup NJOY. Ciena Corp., up $1.80 $50.89. The developer of high-speed networking technology beat Wall Street’s first-quarter profit forecasts. BridgeBio Pharma Inc., up $5.65 to $16.52. The rare disease drug developer gave investors an encouraging development update. Corcept Therapeutics Inc., up $2 to $21.20. The drug developer announced a plan to repurchase stock. Aclaris Therapeutics Inc., down $5.71 to $7.07. The biopharmaceutical company gave investors a discouraging update on a potential skin condition treatment. Qualtrics International Inc., up 13 cents to $17.26. The management company received a buyout offer from Silver Lake Management. IAA, Inc., down $2.87 to $38.32. The auto retailer’s advisors are reportedly recommending against a buyout offer from Ritchie Bros. more…